We are live on !
Find out more
Grace Capital Portfolio holdings
AUM
$168M
Turnover
17.96%
1-Year Est. Return
21.6%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+21.6%
3 Year Est. Return
+126.68%
5 Year Est. Return
+161.89%
10 Year Est. Return
–
AUM
$168M
AUM Growth
+$5.88M
(+3.6%)
Cap. Flow
+$7.04M
Cap. Flow % of AUM
Cap. Flow %
4.18%
Top 10 Holdings %
Top 10 Hldgs %
32.21%
Holding
167
New
6
Increased
63
Reduced
19
Closed
24
Avg Time Held
2.6
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Consumer Discretionary ETF
VCR
|
+$6.52M |
| 2 |
Jasper Therapeutics
JSPR
|
+$2.04M |
| 3 |
Tesla
TSLA
|
+$1.9M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$928K |
| 5 |
NeoGenomics
NEO
|
+$619K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Real Estate ETF
VNQ
|
+$942K |
| 2 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$918K |
| 3 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$915K |
| 4 |
Vanguard Health Care ETF
VHT
|
+$905K |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$892K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.02% |
| 2 | Technology | 18.67% |
| 3 | Healthcare | 17.23% |
| 4 | Consumer Discretionary | 9.91% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Cheniere Energy
CQP
$32B
| $230K | 0.14% |
5,448
+300
| +6% | +$12.6K |
2018 Q4
12 quarters
|
|
127
iShares MSCI India ETF
INDA
$5.71B
| $229K | 0.14% |
5,000
| – | – |
2019 Q4
8 quarters
|
|
128
Caterpillar
CAT
$316B
| $227K | 0.13% |
1,100
+300
| +38% | +$60.4K |
2019 Q1
11 quarters
|
|
129
Ecolab
ECL
$80.9B
| $224K | 0.13% |
953
| – | – |
2019 Q4
8 quarters
|
|
130
Avery Dennison
AVY
$13.8B
| $222K | 0.13% |
1,023
+60
| +6% | +$12.8K |
2020 Q2
6 quarters
|
|
131
Cisco
CSCO
$420B
| $218K | 0.13% |
3,445
| – | – |
2015 Q4
24 quarters
|
|
|
JNCE
132
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $216K | 0.13% |
25,928
| – | – |
2020 Q4
4 quarters
|
|
133
Southwest Airlines
LUV
$20.4B
| $214K | 0.13% |
5,000
| – | – |
2018 Q2
14 quarters
|
|
134
Colgate-Palmolive
CL
$75B
| $213K | 0.13% |
2,500
| – | – |
2018 Q2
14 quarters
|
|
135
DELISTED
VIZIO Holding Corp.
VZIO
| $212K | 0.13% |
10,920
-640
| -6% | -$12.6K |
2021 Q3
1 quarter
|
|
136
Innovative Industrial Properties
IIPR
$1.49B
| $210K | 0.12% |
798
-63
| -7% | -$16.2K |
2021 Q3
1 quarter
|
|
137
TJX Companies
TJX
$160B
| $210K | 0.12% |
2,767
| – | – |
2021 Q3
1 quarter
|
|
138
Hershey
HSY
$34.1B
| $203K | 0.12% |
+1,050
| New | +$190K |
2021 Q4
0 quarters
|
|
139
CACI
CACI
$14B
| $202K | 0.12% |
749
| – | – |
2021 Q3
1 quarter
|
|
140
Brunswick
BC
$4.27B
| $201K | 0.12% |
2,000
| – | – |
2021 Q3
1 quarter
|
|
141
ARK Blockchain & Fintech Innovation ETF
ARKF
$777M
| – | – |
-3,300
| Closed | -$179K | – |
|
142
Bank of America
BAC
$354B
| – | – |
-4,365
| Closed | -$185K | – |
|
143
Healthpeak Properties
DOC
$13.3B
| – | – |
-5,176
| Closed | -$178K | – |
|
144
iShares MSCI Emerging Markets ETF
EEM
$28.7B
| – | – |
-3,000
| Closed | -$157K | – |
|
|
145
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.72B
| – | – |
-8,417
| Closed | -$915K | – |
|
146
L3Harris
LHX
$47.3B
| – | – |
-811
| Closed | -$179K | – |
|
147
Lowe's Companies
LOW
$111B
| – | – |
-1,135
| Closed | -$242K | – |
|
148
LexinFintech Holdings
LX
$105M
| – | – |
-32,100
| Closed | -$192K | – |
|
149
Nurix Therapeutics
NRIX
$2.77B
| – | – |
-6,727
| Closed | -$190K | – |
|
150
PROG Holdings
PRG
$1.21B
| – | – |
-4,200
| Closed | -$195K | – |
|
Similar funds
REMS
TI
NM
KM
MC
FAC
ACM
Grace Capital's Q4 2021 Portfolio in Review
As of Q4 2021, Grace Capital held 167 positions worth $168M, up 3.6% from $163M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Grace Capital deployed $7.04M of net new capital in Q4 2021, opening 6 new positions and adding to 63 existing holdings. Its largest new stake was Jasper Therapeutics: 21,811 shares worth $1.71M.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Ares Capital, an estimated $415K trimmed.
- Grace Capital's largest Q4 2021 buy was Jasper Therapeutics: 21,811 shares worth $1.71M.
- Grace Capital added most to Vanguard Consumer Discretionary ETF in Q4 2021, an estimated $6.52M increase.
- Grace Capital's biggest Q4 2021 reduction was Ares Capital, cutting an estimated $415K.
- Grace Capital fully exited Vanguard Real Estate ETF in Q4 2021, selling an estimated $942K.
- Grace Capital's ten largest holdings make up 32% of its $168M portfolio in Q4 2021.
- Grace Capital opened 6 new positions and closed 24 in Q4 2021.
- Grace Capital's portfolio value rose 3.6% quarter-over-quarter to $168M.
Based on Grace Capital's 13F filing for Q4 2021, filed 2 Feb 2022.